Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes – Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes

By sjmartinez • November 28, 2023

Pyatak EA, Ali A, Khurana AR, Lee PJ, Sideris J, Fox S, Diaz J, Granados G, Blanchard J, McGuire R, Salazar Plascencia E, Salcedo-Rodriguez E, Flores-Garcia J, Linderman M, Taylor EE, Tapia V, Nnoli N, Sequeira PA, Freeby MJ, Raymond JK. Research design and baseline participant characteristics of the Resilient, Empowered, Active Living with Diabetes - Telehealth (REAL-T) Study: A randomized controlled trial for young adults with type 1 diabetes. Contemp Clin Trials. 2023 Dec;135:107386. doi: 10.1016/j.cct.2023.107386. Epub 2023 Nov 4. PMID: 37931702.

Tags: Endocrinology, Lifestyle intervention, Occupational therapy, Publications, Randomized Controlled Trial, Type 1 diabetes, young adults

Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist Therapy: The Emerging Role of Oral Agents

Wang SY, Stofer R, Wang H, Brent GA, Shi L, Cai Y, Roosan M, Moin T. Bridging Efficacy and Adherence in Glucagon-Like Peptide-1 Receptor Agonist[...]

Impact of a Nurse Practitioner-Led Diabetes Program on Barriers to CGM Use in a Federally Qualified Health Center After Medicaid Expansion

Scarlett LD, Solorzano W, Khoshbin K, Villanueva GP, Mangual KS, Tavares M, Santana C, Escobar B, Borrell J, Brumley B, Moin T, Everett E. Impact[...]

Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact

Chew L, Feng J, Hutchins E, Stein-Merlob AF, Yang EH, Lechner MG, Tsui E. Immune Checkpoint Inhibitor-Associated Uveitis: Predictors and Survival Impact. Ophthalmol Retina. 2025[...]